Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2630

Actual shortage: 256 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2365 (90%)

Discontinuation Reports

249

To be discontinued: 3 (1%)
Discontinued: 246 (99%)
Reversed: 0 (0%)

Late reports

318 (11%)

Overdue reports

22 (8%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-TADALAFIL 5MG TABLET Actual shortage 2024-03-28 2024-03-29 223859
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-28 2024-03-29 223862
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-28 2024-03-28 223856
TEVA-CANDESARTAN 32MG TABLET Actual shortage 2024-03-28 2024-03-28 223853
TEVA-EZETIMIBE 10MG TABLET Actual shortage 2024-03-28 2024-03-28 223850
TEVA-TELMISARTAN 80MG TABLET Actual shortage 2024-03-28 2024-03-28 223847
TEVA-OLANZAPINE 5MG TABLET Actual shortage 2024-03-28 2024-03-28 223844
TEVA-METFORMIN 500MG TABLET Actual shortage 2024-03-28 2024-03-28 223841
TEVA-CYCLOBENZAPRINE 10MG TABLET Actual shortage 2024-03-28 2024-03-28 223838
TEVA-DOXYCYCLINE 100MG CAPSULE Actual shortage 2024-03-28 2024-03-28 223835
TEVA-ECTOSONE 0.05% LOTION Actual shortage 2024-03-28 2024-03-28 223832
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Actual shortage 2024-03-07 2024-03-28 221534
TEVA-BUPRENORPHINE/NALOXONE 2MG 8MG TABLET Actual shortage 2024-03-07 2024-03-28 221537
TEVA-CEPHALEXIN 125 125MG POWDER FOR SUSPENSION Resolved 2023-11-23 2024-03-28 211316
TEVA-VALGANCICLOVIR 450MG TABLET Resolved 2023-11-16 2024-03-28 210440
TEVA-CEPHALEXIN 500MG TABLET Resolved 2024-02-15 2024-03-28 219687
TEVA-CEPHALEXIN 500MG TABLET Resolved 2024-02-08 2024-03-28 218943
TEVA-MOMETASONE 50MCG SPRAY, METERED DOSE Actual shortage 2024-01-11 2024-03-28 215760
TEVA-BUDESONIDE 0.5MG SUSPENSION Actual shortage 2023-06-19 2024-03-28 195478
TEVA-ESOMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Actual shortage 2024-03-07 2024-03-28 221552

Showing 1 to 20 of 2630

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LISINOPRIL (TYPE P) 20MG TABLET Discontinued 2020-01-24 2020-01-24 104257
TEVA-DEFERASIROX 250MG TABLET FOR SUSPENSION Discontinued 2020-01-21 2020-01-21 103796
TEVA-DEFERASIROX 125MG TABLET FOR SUSPENSION Discontinued 2020-01-21 2020-01-21 103791
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-ATENOLOL/CHLORTHALIDONE 25MG 100MG TABLET Discontinued 2020-01-21 2020-01-21 103781
TEVA-PAROXETINE 20MG TABLET Discontinued 2019-12-09 2019-12-09 100547
TEVA-PAROXETINE 30MG TABLET Discontinued 2019-12-09 2019-12-09 100540
ACT NABILONE 1MG CAPSULE Discontinued 2019-10-31 2019-11-01 97581
TEVA-DEFERASIROX 500MG TABLET FOR SUSPENSION Discontinued 2019-10-31 2019-11-01 97589
TEVA-DIVALPROEX 125MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97232
TEVA-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97235
TEVA-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97238
RATIO-NYSTATIN 100000UNIT CREAM Discontinued 2019-10-25 2019-10-26 97243
TEVA-DEFERASIROX 500MG TABLET FOR SUSPENSION Discontinued 2019-10-25 2019-10-26 97248
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-10-25 2019-10-26 97251
RATIO-NYSTATIN 100000UNIT CREAM Discontinued 2019-10-25 2019-10-26 97261
TEVA-ARIPIPRAZOLE 15MG TABLET Discontinued 2019-10-25 2019-10-26 97264
TEVA-ARIPIPRAZOLE 20MG TABLET Discontinued 2019-10-25 2019-10-26 97267
TEVA-HALOPERIDOL 20MG TABLET Discontinued 2019-10-25 2019-10-26 97270
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2019-10-25 2019-10-26 97256

Showing 101 to 120 of 249